Eni i-Sigma universal 10W-40

Hazard statements (CLP)

H317, H319

Code

Statements

H317

May cause an allergic skin reaction

SECTION 2: Hazards identification

According to Regulation (EC) No. 1272/2008 (CLP)] Classification of the substance or mixture

Adverse physicochemical, human health and environmental effects

Prolonged and repeated skin contact may cause reddening, irritation and dermatitis. May produce an allergic reaction. For specific information about the toxicological/ecotoxicological properties and classification of this product, see Sect. 11 and/or Sect. 12

Hazard pictograms

GHS07

Signal word

Warning

Contains

Alkyl (C18-C28) toluenesulfonic acid, calcium salts, borated; Benzenesulfonic acid, methyl-, mono-C20-24-branched alkyl derivs., calcium salts

Hazard statements

H317 - May cause an allergic skin reaction. H319 - Causes serious eye irritation.

Precautionary statements

P101 - If medical advice is needed, have product container or label at hand. P102 - Keep out of reach of children. P280 - Wear protective gloves, protective clothing, eye protection, face protection. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P321 - Specific treatment (see supplemental first aid instruction on this label). P501 - Dispose of contents and container to according to national or local regulations. 2.3. Other hazards (not relevant for classification)

Other hazards which do not result in classification

This product is combustible, but not classified as Flammable. The creation of flammable vapour mixtures takes place at temperatures which are higher than normal ambient levels. In case of contact with eyes, this product may cause irritation. If the product is handled or used at high temperature, contact with hot product or vapours may cause burns. Any substance, in case of accidents involving pressurized circuits and the like, may be accidentally injected under the skin, even without external damage. In such a case, the victim should be brought to an hospital as soon as possible, to get specialized medical treatment. Do not wait for symptoms to develop. A potential risk may arise from the release of hydrogen sulfide, when the product is stored or handled at high temperature. Hydrogen sulfide may accumulate in the tanks or other confined spaces, with danger to the workers that enter the spaces. In these cases overexposure to hydrogen sulfide may cause irritation to airways, nausea, dizziness, loss of consciousness and death. This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII

Further information

The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %. Component Distillates (petroleum), hydrotreated heavy paraffinic This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII (64742-54-7) This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII Distillates (petroleum), hydrotreated heavy paraffinic This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII (64742-54-7) This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII Distillates (petroleum), solvent-refined light paraffinic This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII (64741-89-5) This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII Phosphorodithioic acid, mixed O,O-bis(sec-Bu and This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII 1,3-dimethylbutyl) esters, zinc salts (68784-31-6) This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII Alkyl (C18-C28) toluenesulfonic acid, calcium salts, This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII borated This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII Component Benzenesulfonic acid, methyl-, mono-C20-24- This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII branched alkyl derivs., calcium salts (722503-68-6) This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII Distillates (petroleum), solvent-dewaxed heavy This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII paraffinic (64742-65-0) This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 % Component Distillates (petroleum), hydrotreated heavy The substance is not included in the list established in accordance with Article 59(1) of paraffinic(64742-54-7) REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 Distillates (petroleum), hydrotreated heavy The substance is not included in the list established in accordance with Article 59(1) of paraffinic(64742-54-7) REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 Distillates (petroleum), solvent-dewaxed heavy The substance is not included in the list established in accordance with Article 59(1) of paraffinic(64742-65-0) REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 Distillates (petroleum), solvent-refined light The substance is not included in the list established in accordance with Article 59(1) of paraffinic(64741-89-5) REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 Phosphorodithioic acid, mixed O,O-bis(sec-Bu and The substance is not included in the list established in accordance with Article 59(1) of 1,3-dimethylbutyl) esters, zinc salts(68784-31-6) REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 Alkyl (C18-C28) toluenesulfonic acid, calcium salts, The substance is not included in the list established in accordance with Article 59(1) of borated REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 Benzenesulfonic acid, methyl-, mono-C20-24- The substance is not included in the list established in accordance with Article 59(1) of branched alkyl derivs., calcium salts(722503-68-6) REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605

2.1 Classification of the substance or mixture

Classification according to Regulation (EC) No. 1272/2008 [EU-GHS / CLP] Serious eye damage/eye irritation, Category 2 H319 Skin sensitisation, Category 1 H317 Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects Prolonged and repeated skin contact may cause reddening, irritation and dermatitis. May produce an allergic reaction. For specific information about the toxicological/ecotoxicological properties and classification of this product, see Sect. 11 and/or Sect. 12.